Eargo, Inc.

NasdaqGS:EAR Aktierapport

Börsvärde: US$53.4m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Eargo Förvaltning

Förvaltning kriterier kontrolleras 2/4

Eargo VD är Bill Brownie, utsedd i Dec 2016, har en mandatperiod på 7.17 år. totala årliga ersättningen är $ 625.20K, bestående av 62.4% lön 37.6% bonusar, inklusive företagsaktier och optioner. äger direkt 0% av företagets aktier, värda $ 229.56. Den genomsnittliga mandatperioden för ledningsgruppen och styrelsen är 1.4 år respektive 1.2 år.

Viktig information

Bill Brownie

Verkställande direktör

US$625.2k

Total ersättning

VD-lön i procent62.38%
Anställning som VD7.2yrs
Ägande av VD0.0004%
Ledningens genomsnittliga anställningstid1.4yrs
Styrelsens genomsnittliga mandatperiod1.2yrs

Senaste uppdateringar av ledningen

Recent updates

Seeking Alpha • Aug 30

Eargo: Straining To Be Heard

Summary Today, we take our first look at a small medical device company called Eargo, Inc. whose stock has slumped 90% over the past year. A good portion of the decline was caused by two key issues, both of which company management is hoping to put in the rearview mirror. An investment analysis follows in the paragraphs below. The art of conversation is the art of hearing as well as of being heard."― William Hazlitt Today, we put Eargo, Inc.(EAR) in the spotlight for the first time. This company has a variety of issues recently that have caused the stock to nosedive deep into 'Busted IPO' territory. Are brighter times on the horizon? An analysis follows below. Seeking Alpha Company Overview: Eargo, Inc. is a small medical device maker headquartered in San Jose, CA. The company markets and sells hearing aids through direct-to-consumer and through omni-channels. The stock currently has an approximate market capitalization of $75 million. The company launched the latest version of its hearing aid line, the Eargo 6 in January of this year. The Eargo 6 is an FDA Class II exempt hearing device featuring Sound Adjust technology that automatically optimizes the soundscape as the user moves between environments. June Company Presentation The company has been dogged by two major issues since it went public. The first was a criminal investigation initiated by the U.S. Department of Justice related to insurance reimbursement claims submitted by the company on behalf of its customers covered by the Federal Employee Health Benefits (FEHB) program. Management denied wrongdoing but settled this issue for $34.4 million in the Spring of this year. June Company Presentation Eargo also no longer accepted insurance as a method of direct payment in late 2021. In the second quarter of this year, Eargo operated on a cash-pay only basis which tanked sales (see section below). The company did get some very good news on this front two weeks ago as the FDA disclosed it would allow the sale of some hearing aids over the counter beginning in October. June Company Presentation The company has shipped over 110,000 hearing aid devices in its history and believes the market is significantly underpenetrated especially for its in-ear devices that offer several advantages to traditional hearing aids. June Company Presentation Second Quarter Results: On August 8th, the company posted second quarter numbers. The company had a GAAP loss of 78 cents a share as revenues plunged nearly 70% on a year-over-year basis to $7.25 million. Both top and bottom lines missed expectations badly. Returns rose to a third of sales from just less than a quarter in the same period a year ago. GAAP gross margin was 34.7%, compared to 71.8% in 2Q2021. Management stated via its earnings press release, the company would be focused on four key areas going forward. Eargo's omni-channel growth strategy Potentially regaining insurance coverage of Eargo for government employees under the FEHB program Refining and expanding the company's physical retail strategy Optimize the cash-pay business while continuing to invest in innovation. June Company Presentation Analyst Commentary & Balance Sheet: Wells Fargo ($10 price target), JPMorgan ($11 price target) and William Blair either maintained or downgraded Eargo to a Hold in the fourth quarter of 2021, but no analyst firms I can find have issued any ratings on Eargo so far in 2022. Just over one out of every ten shares are currently held short. Two insiders sold just over $40,000 in aggregate earlier this month. Another insider sold less than $15,000 worth of equity in March. That has been the only insider activity in Eargo's shares so far in 2022. The company ended the second quarter of the year with just over $106 million in cash and marketable securities on its balance sheet. This is almost entirely due to an issuance of $100 million senior secured convertible notes that occurred late in June. This is the core tranche of a $125 million strategic investment from Patient Square Capital. $16.2 million of these proceeds were used to pay off a previous debt obligation. Management will seek stockholder approval to increase the number of authorized shares and issue full potential amount of note conversion shares at its annual meeting in October of this year. If approved, this will consist of new shares of common stock created by a rights offering.
Seeking Alpha • Aug 16

Eargo jumps 77% following FDA rule on OTC hearing aids

Microcap Eargo (NASDAQ:EAR) closed up 77% on Tuesday following the U.S. FDA's announcement that it would allow the sale of some hearing aids over the counter beginning in October. Average daily volume for the company is ~4.2M shares. ~31.8M shares traded hands on Tuesday. Seeking Alpha's Quant Rating views Eargo (EAR) as a strong sell.
Seeking Alpha • Aug 08

Eargo Non-GAAP EPS of -$0.78 misses by $0.55, revenue of $7.25M misses by $21.05M

Eargo press release (NASDAQ:EAR): Q2 Non-GAAP EPS of -$0.78 misses by $0.55. Revenue of $7.25M (-68.3% Y/Y) misses by $21.05M.
Seeking Alpha • Jul 05

Eargo completes $100M senior secured convertible notes issuance

Medical device company Eargo (NASDAQ:EAR) completed the issuance of $100M senior secured convertible notes to Patient Square Capital on Jun. 28. ~$16.3M of the net proceeds was used to repay all existing third-party indebtedness and related pay-off expenses. The remaining proceeds are intended to be used for working capital purposes and to fund general business requirements. Source: Press Release
Seeking Alpha • Dec 30

Eargo: A Binary Play On Hearing Loss

Eargo has exhibited stupendous sales growth in recent years and that looks set to continue. But this growth comes at the cost of significant cash outflows that have largely increased over time. The company's value is implied to be very small at this time, which could lead to significant upside if things go right. But significant risks definitely exist, making the company a binary prospect currently.
Seeking Alpha • Oct 08

Eargo Is A High Risk 'Option' With High Potential

Eargo Inc. is a US-based small-cap public company that manufactures and distributes Completely-In-Canal (CIC) hearing aids throughout the country. The company will be one of the beneficiaries of promoting sales of OTC hearing aids in the United States. Eargo Inc. has created a highly competitive product that meets high-quality standards at an affordable price.
Analysartikel • Jul 10

An Intrinsic Calculation For Eargo, Inc. (NASDAQ:EAR) Suggests It's 23% Undervalued

In this article we are going to estimate the intrinsic value of Eargo, Inc. ( NASDAQ:EAR ) by estimating the company's...
Analysartikel • Jan 16

What Kind Of Investors Own Most Of Eargo, Inc. (NASDAQ:EAR)?

If you want to know who really controls Eargo, Inc. ( NASDAQ:EAR ), then you'll have to look at the makeup of its share...

Analys av ersättningar till VD

Hur har Bill Brownie:s ersättning förändrats jämfört med Eargo:s resultat?
DatumTotal ersättningLönFöretagets resultat
Sep 30 2023n/an/a

-US$108m

Jun 30 2023n/an/a

-US$141m

Mar 31 2023n/an/a

-US$149m

Dec 31 2022US$625kUS$390k

-US$157m

Sep 30 2022n/an/a

-US$159m

Jun 30 2022n/an/a

-US$188m

Mar 31 2022n/an/a

-US$175m

Dec 31 2021US$2mUS$369k

-US$158m

Sep 30 2021n/an/a

-US$124m

Jun 30 2021n/an/a

-US$45m

Mar 31 2021n/an/a

-US$32m

Dec 31 2020US$1mUS$258k

-US$30m

Sep 30 2020n/an/a

-US$32m

Jun 30 2020n/an/a

-US$44m

Mar 31 2020n/an/a

-US$47m

Dec 31 2019US$531kUS$300k

-US$44m

Sep 30 2019n/an/a

-US$42m

Dec 31 2018US$300kUS$300k

-US$34m

Ersättning vs marknad: Bill s total kompensation ($USD 625.20K ) är ungefär genomsnittet för företag av liknande storlek på US marknaden ($USD 647.77K ).

Ersättning vs inkomst: Ersättningen från Bill har varit i linje med företagets resultat under det senaste året.

VD OCH KONCERNCHEF

Bill Brownie (55 yo)

7.2yrs
Anställning
US$625,200
Kompensation

Mr. William H. Brownie, also known as Bill, serves as Chief Operating Officer at Eargo, Inc. since April 2019 and also serves as Interim Chief Executive Officer since July 2023. Mr. Brownie served as Chief...

Ledningsgrupp

NamnPositionAnställningKompensationÄgarskap
William Brownie
Interim CEO & COO7.2yrsUS$625.20k0.00043%
$ 229.6
Daniel Shen
Co-Founder and Chief Clinical & Science Officerno datainga uppgifteringa uppgifter
Mark Thorpe
Chief Financial Officerless than a yearinga uppgifter0.00015%
$ 80.1
Tim Trine
Chief Technology Officer1.4yrsinga uppgifteringa uppgifter
Christy La Pierre
Chief Legal Officer & Secretaryno datainga uppgifteringa uppgifter
Tricia Burchell
Senior Vice President of People Operationsno datainga uppgifteringa uppgifter
1.4yrs
Genomsnittlig anställningstid

Erfaren ledning: EAR s ledningsgrupp anses inte vara erfaren ( 1.4 års genomsnittlig anställningstid), vilket föreslår ett nytt team.

Styrelseledamöter

NamnPositionAnställningKompensationÄgarskap
David Wu
Independent Director9.6yrsUS$180.25k0.12%
$ 65.4k
Katherine Bayne
Independent Director2.7yrsUS$174.74k0%
$ 0
Donald Spence
Independent Chairman of the Board1.2yrsUS$54.85k0%
$ 0
Justin Sabet-Peyman
Director1.2yrsUS$53.49k0%
$ 0
Karr Narula
Director1.2yrsUS$51.79k0%
$ 0
Trit Garg
Director1.2yrsUS$52.64k0%
$ 0
1.2yrs
Genomsnittlig anställningstid
49yo
Genomsnittlig ålder

Erfaren styrelse: EAR s styrelse anses inte vara erfaren ( 1.2 års genomsnittlig mandatperiod), vilket föreslår en ny styrelse.

Företagsanalys och finansiella data Status

UppgifterSenast uppdaterad (UTC-tid)
Analys av företag2024/02/20 05:33
Aktiekurs vid dagens slut2024/02/20 00:00
Intäkter2023/09/30
Årlig intjäning2022/12/31

Datakällor

Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.

PaketUppgifterTidsramExempel US-källa
Företagets finansiella ställning10 år
  • Resultaträkning
  • Kassaflödesanalys
  • Balansräkning
Analytikernas konsensusuppskattningar+3 år
  • Prognos för finansiella poster
  • Analytikernas prismål
Marknadspriser30 år
  • Aktiekurser
  • Utdelningar, splittar och åtgärder
Ägarskap10 år
  • Största aktieägare
  • Insiderhandel
Förvaltning10 år
  • Ledningsgrupp
  • Styrelse och verkställande direktörer
Viktiga utvecklingstendenser10 år
  • Företagsmeddelanden

* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.

Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.

Analysmodell och snöflinga

Detaljer om analysmodellen som används för att skapa denna rapport finns på vår Github-sida; vi har också guider om hur du använder våra rapporter och handledningar på Youtube.

Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.

Industri- och sektormått

Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.

Källor för analytiker

Eargo, Inc. bevakas av 4 analytiker. av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.

AnalytikerInstitution
Robert HopkinsBofA Global Research
Robert MarcusJ.P. Morgan
Lawrence BiegelsenWells Fargo Securities, LLC